DCLK2 Antibody

Introduction to DCLK2 Antibody

DCLK2 antibodies are immunological reagents specifically designed to detect and bind to Doublecortin-Like Kinase 2 protein. These antibodies are critical research tools that enable the visualization, quantification, and characterization of DCLK2 expression patterns in various biological contexts. The development of highly specific antibodies against different epitopes of DCLK2 has significantly advanced our understanding of this protein's distribution and function in normal physiology and disease states .

DCLK2, also known by several alternative names including DCAMKL2, DCDC3B, DCK2, CL2, CLIK2, CLICK2, and CLICK-II, belongs to a family of proteins characterized by dual functional domains . The significance of these antibodies extends beyond basic research into potential clinical applications, as DCLK2 has been implicated in various neurological conditions and developmental processes .

Structure and Function of DCLK2 Protein

Understanding the structure and function of DCLK2 is essential for appreciating the importance of antibodies targeting this protein. DCLK2 features a complex molecular architecture consisting of multiple functional domains that confer its diverse biological activities.

Molecular Structure

DCLK2 is characterized by a distinctive domain organization that includes:

1. Two N-terminal doublecortin domains that bind microtubules and regulate microtubule polymerization

2. A C-terminal serine/threonine protein kinase domain showing substantial homology to Ca²⁺/calmodulin-dependent protein kinase

3. A serine/proline-rich domain situated between the doublecortin and protein kinase domains that mediates multiple protein-protein interactions

The predicted molecular weight of the full-length DCLK2 protein is approximately 83-85 kDa, which serves as an important reference point when evaluating antibody specificity in immunoblotting applications .

Functional Significance

DCLK2 exhibits several key functions that highlight its biological importance:

1. Microtubule regulation: DCLK2 binds to microtubules and influences their polymerization, a function that is independent of its protein kinase activity

2. Neuronal development: Together with other doublecortin family members, DCLK2 plays critical roles in the establishment of hippocampal organization

3. Kinase activity: DCLK2 demonstrates a significantly reduced Ca²⁺/CAM affinity and dependence compared to other members of the CaMK family

Research in mouse models has revealed that DCLK2, along with DCX (another family member), contributes to neuronal development. While DCLK1 expression increases in DCX-null mice, DCLK2 expression remains unchanged, suggesting distinct functional roles for different family members .

Types of DCLK2 Antibodies

The commercial market offers a diverse range of DCLK2 antibodies, each with specific characteristics suitable for different experimental applications. These antibodies can be categorized based on various parameters including host species, clonality, epitope specificity, and conjugation status.

Classification Based on Host and Clonality

Available DCLK2 antibodies are primarily derived from rabbit and mouse host systems, with both polyclonal and monoclonal variants available . The choice between these options depends on the specific requirements of the intended application:

Polyclonal antibodies, such as those detailed in catalog entries ABIN3184260 and ABIN3030772, offer the advantage of recognizing multiple epitopes on the DCLK2 protein, potentially enhancing detection sensitivity .

Classification Based on Epitope Specificity

DCLK2 antibodies target different regions of the protein, providing researchers with options for examining specific domains:

1. N-terminal antibodies: Target the doublecortin domains (e.g., antibodies recognizing amino acids 1-50, 167-196)

2. Middle region antibodies: Recognize the serine/proline-rich domain (e.g., antibodies targeting amino acids 348-438)

3. C-terminal antibodies: Directed against the kinase domain (e.g., antibodies specific for amino acids 652-766)

This diversity enables researchers to select antibodies appropriate for detecting specific DCLK2 isoforms or investigating particular functional domains .

Applications of DCLK2 Antibodies in Research

DCLK2 antibodies serve as valuable tools across multiple experimental platforms, enabling researchers to investigate the expression, localization, and function of DCLK2 in various biological contexts.

Western Blotting (WB)

Western blotting represents one of the most common applications for DCLK2 antibodies. In this technique, these antibodies enable the detection and semi-quantification of DCLK2 protein in tissue or cell lysates:

1. The expected band size for full-length DCLK2 is approximately 83-85 kDa

2. Some antibodies may detect additional isoforms or splice variants

3. Recommended dilutions typically range from 1:500 to 1:3000

Evidence from validation studies shows successful detection of endogenous DCLK2 in various samples including human cell lines (293 cells) and rat brain tissue lysates .

Enzyme-Linked Immunosorbent Assay (ELISA)

Many DCLK2 antibodies are validated for ELISA applications, allowing for quantitative measurement of DCLK2 protein levels:

Immunohistochemistry (IHC) and Immunofluorescence (IF)

DCLK2 antibodies enable the visualization of protein expression patterns in tissue sections and cultured cells:

1. These applications reveal the spatial distribution of DCLK2 within tissues and subcellular compartments

2. IHC has been used to detect DCLK2 in brain tissues, providing insights into its neuroanatomical distribution

3. IF studies have demonstrated DCLK2 localization in dendritic structures, supporting its role in neuronal development

Research published in Nature Communications utilizing DCLK antibodies demonstrated that DCLK proteins (including DCLK2) are enriched in dendrites of cultured hippocampal neurons, with preferential localization to distal dendritic segments during early developmental stages .

Research Findings and Biological Significance

DCLK2 antibodies have contributed significantly to our understanding of this protein's expression patterns and functional roles in various biological contexts.

Neuronal Development and Function

Research utilizing DCLK2 antibodies has revealed important insights into the protein's role in neuronal development:

1. DCLK2 expression is maintained in postnatal neurons in both cerebral cortex and hippocampus

2. The protein shows specific temporal expression patterns, with peak levels observed in the hippocampus around postnatal day 14

3. DCLK2, together with other family members, contributes to hippocampal organization and dendritic morphogenesis

Studies have shown that DCLK proteins, including DCLK2, localize to distal dendrites and promote their growth by enhancing microtubule bundling. Additionally, they suppress maturation of synapses through multiple pathways, identifying them as critical regulators of dendritic development .

Association with Human Conditions

DCLK2 has been implicated in several human conditions, highlighting the clinical relevance of antibodies targeting this protein:

1. Genome-wide association studies have linked DCLK2 to adipose distribution, particularly visceral fat in women

2. Genetic associations have been identified between DCLK2 and autistic-like traits

3. The protein's similarity to DCX, which is mutated in X-linked lissencephaly, suggests potential roles in neurodevelopmental disorders

These findings emphasize the value of DCLK2 antibodies in both basic research and translational medicine contexts.

Validation Methods and Quality Control

The reliability of DCLK2 antibodies depends on rigorous validation procedures that confirm their specificity and performance across intended applications.

Specificity Validation

Several approaches are employed to validate antibody specificity:

1. Western blotting with positive and negative control samples

2. RNAi-mediated knockdown experiments to confirm signal reduction

3. Comparison of reactivity patterns between different antibodies targeting distinct epitopes

4. Testing in samples from knockout models where available

For example, validation studies mentioned in search result confirmed antibody specificity through significant reduction of immunoreactivity in primary neurons transfected with RNA interference constructs for both DCLK1 and DCLK2.

Quality Control Parameters

Commercial DCLK2 antibodies undergo various quality control procedures to ensure consistent performance:

1. Purification methods: Many antibodies are affinity-purified using epitope-specific immunogens

2. Lot-to-lot testing: Ensures consistency between different production batches

3. Cross-reactivity assessment: Evaluates potential binding to related proteins

4. Application-specific validation: Confirms performance in each advertised application

These measures help researchers select antibodies with demonstrated reliability for their specific experimental needs.